February 11, 2008 - The American Society of Echocardiography (ASE) has issued a new consensus statement for interpreting ...
February 11, 2008 - Boston Scientific Corp. today announced that the first patient has been enrolled in its PROENCY ...
Toshiba’s Cardio Prospective helps reduce patient radiation dose by up to 80 percent during coronary CTA exams by using a helical acquisition technique to provide one continuous image instead of multiple images produced by the current step-and-shoot technique.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 11, 2008 - The first patient was successfully treated in AtriCure’s ABLATE clinical trial designed to evaluate ...
February 8, 2008 - The FDA granted Volcano Corp. 510(k) clearance for its s5-Revo and s5-FFR (fractional flow reserve) options, allowing physicians access phased Array IVUS, Rotational IVUS and integrated FFR on the same integrated IVUS platform.
February 8, 2008 – CryoLife Inc. said it received FDA 510(k) clearance for its CryoValve SG pulmonary human heart valve ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 8, 2008 - Emageon received first place in the “Best in KLAS” Top 20 Report for the Cardiology PACS nomination ...
Emageon's HeartSuite offers cardiovascular information management, hemodynamic monitoring, advanced visualization and content management. Emageon’s architecture combines HeartSuite with radiology and other medical specialties designed to offer a comprehensive patient–centric view of the visual medical record. One suite of integrated, enterprise cardiology tools includes:
February 7, 2008 - Volcano Corp. said the FDA cleared the s5-Revo and s5-FFR (fractional flow reserve) options, enabling ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 8, 2008 - CryoLife Inc. received 510(k) clearance from the FDA for its CryoValve SG pulmonary human heart valve processed with the company’s proprietary SynerGraft technology, providing a valve replacement option for children born with heart defects or for replacement surgery.
CryoLife Inc.'s CryoValve SG pulmonary human heart valve is processed with the company’s proprietary SynerGraft technology, providing a valve replacement option for children born with heart defects or for replacement surgery.
February 8, 2008 - The FDA granted Volcano Corp. 510(k) clearance for its s5-Revo and s5-FFR (fractional flow reserve) options, allowing physicians access phased Array IVUS, Rotational IVUS and integrated FFR on the same integrated IVUS platform.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
February 7, 2008 - Abiomed Inc. reported its third quarter fiscal 2008 revenue reached $16.0 million, up 24 percent ...
The PicomECG is a reportedly flexible and robust Web-based ECG management and distribution system.
February 7, 2008 - Tryton Medical Inc.’s Side Branch Stent obtains CE Mark approval based on results in the Tryton 1 (First-in-Man Study) with No Side-Branch Restenosis in 30 patients, according to the manufacturer.